ES2078550T3 - Aerosol que contiene medicamentos. - Google Patents

Aerosol que contiene medicamentos.

Info

Publication number
ES2078550T3
ES2078550T3 ES91919478T ES91919478T ES2078550T3 ES 2078550 T3 ES2078550 T3 ES 2078550T3 ES 91919478 T ES91919478 T ES 91919478T ES 91919478 T ES91919478 T ES 91919478T ES 2078550 T3 ES2078550 T3 ES 2078550T3
Authority
ES
Spain
Prior art keywords
amino
aerosol containing
containing medicines
benzenemethanol
salmeterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919478T
Other languages
English (en)
Inventor
Anthony James Taylor
Patricia Kwong Phieu Burnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2078550T3 publication Critical patent/ES2078550T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTAN FORMULACIONES DE AEROSOL QUE CONTINEN: (A) UN MEDICAMENTO SELECCIONADO ENTRE EL GRUPO QUE CONSTA DE SALMETEROL, ESTERES DE FLUTICASONA, BENCENOMETANOL DE 4-AMINO-3,5-DICLORO-(ALFA)[[[6-[2-(2-PIRIDINIL)ETOXI]HEXIL]AMINO]METIL] Y LAS SALES FISIOLOGICAMENTE ACEPTABLES Y LOS SOLVATOS DE LOS MISMOS EN FORMA DE PARTICULAS Y QUE TIENEN UN REVESTIMIENTO SUPERFICIAL DE UN SURFACTANTE; Y (B) UN PROPELENTE DE FLUOROCARBONO O CLOROFLUOROCARBONO CON CONTENIDO DE HIDROGENO; ASIMISMO SE PRESENTA UN METODO PARA SU PREPARACION.
ES91919478T 1990-11-09 1991-11-07 Aerosol que contiene medicamentos. Expired - Lifetime ES2078550T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024366A GB9024366D0 (en) 1990-11-09 1990-11-09 Medicaments

Publications (1)

Publication Number Publication Date
ES2078550T3 true ES2078550T3 (es) 1995-12-16

Family

ID=10685110

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919478T Expired - Lifetime ES2078550T3 (es) 1990-11-09 1991-11-07 Aerosol que contiene medicamentos.

Country Status (11)

Country Link
EP (1) EP0556239B1 (es)
JP (1) JP3468767B2 (es)
AT (1) ATE127012T1 (es)
AU (1) AU653369B2 (es)
CA (1) CA2094727C (es)
DE (1) DE69112635T2 (es)
DK (1) DK0556239T3 (es)
ES (1) ES2078550T3 (es)
GB (1) GB9024366D0 (es)
GR (1) GR3018171T3 (es)
WO (1) WO1992008447A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2381329C (en) * 1991-12-12 2003-04-15 Glaxo Group Limited Medicaments
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE69432224T2 (de) * 1993-12-02 2003-12-04 Abbott Lab Aerosole als darreichungsform mit cfc-freiem treibmittel
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
PT1169019E (pt) * 1999-04-14 2003-07-31 Glaxo Group Ltd Formulacao farmaceutica em aerossol
ES2689704T3 (es) 2000-11-30 2018-11-15 Vectura Limited Partículas para usar en una composición farmacéutica
GB0107106D0 (en) * 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0130703D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Particles
CN1791386A (zh) * 2003-05-19 2006-06-21 巴克斯特国际公司 抗癫痫和抗痴呆药物以及免疫抑制剂的小－颗粒药物制剂
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
US8652443B2 (en) 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
HUE042556T2 (hu) 2011-10-11 2019-07-29 Chiesi Farm Spa Zsírsavval bevont béta-agonista kristályos mikrorészecskéi
CN114515284A (zh) 2016-09-19 2022-05-20 墨西哥氟石股份公司 药物组合物
ES2877575T3 (es) 2016-09-19 2021-11-17 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende salmeterol
CN109715160A (zh) 2016-09-19 2019-05-03 墨西哥氟石股份公司 药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen

Also Published As

Publication number Publication date
CA2094727C (en) 2002-01-15
EP0556239A1 (en) 1993-08-25
JP3468767B2 (ja) 2003-11-17
WO1992008447A1 (en) 1992-05-29
DE69112635T2 (de) 1996-02-08
AU653369B2 (en) 1994-09-29
JPH06501693A (ja) 1994-02-24
GR3018171T3 (en) 1996-02-29
ATE127012T1 (de) 1995-09-15
DK0556239T3 (da) 1995-11-06
GB9024366D0 (en) 1991-01-02
EP0556239B1 (en) 1995-08-30
AU8862991A (en) 1992-06-11
CA2094727A1 (en) 1992-05-10
DE69112635D1 (de) 1995-10-05

Similar Documents

Publication Publication Date Title
ES2078550T3 (es) Aerosol que contiene medicamentos.
ATE127013T1 (de) Aerosolzusammensetzungen.
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
ES2189410T3 (es) Formulacion farmaceutica en aerosol.
PT918507E (pt) Formulacoes em aerossol
FI90014B (fi) Foerfarande foer loesning av ett laekemedel som loeser sig daoligt i klorfluorkolvaete-aerosoldrivmedel
NO972781L (no) Aerosolformuleringer av peptider og proteiner
AR002009A1 (es) Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
NO972681L (no) Aerosol legemiddel formuleringer
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
ATE195249T1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
CA2402300A1 (en) Fluorocarbon aerosol medicaments
AU9124191A (en) Flexible bag for packaging compressed products
DE60001492D1 (de) Pharmazeutische aerosolformulierung
ATE287699T1 (de) Pharmazeutische aerosolzusammensetzungen
GR3017949T3 (en) Lateral edge coated controlled release pharmaceutical compositions.
IE900391L (en) N-(3-pyridyl) guanidine derivative
SE9101687L (sv) Dikloranilinfoerening
NO971519L (no) Fremgangsmåte for fremstilling av antigenisk forsterkede enterier og vaksiner inneholdende disse
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
SE9702545L (sv) Absorberande alster och metod att tillverka detsamma
IT8919370A0 (it) Metodo per ridurre gli effetti irritativi locali di preparazione farmaceutiche e composizioni cosi' ottenute.
IT1229202B (it) Gratinatore per la preparazione industriale di piatti pronti preconfezionati in vaschetta.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 556239

Country of ref document: ES